SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

CPO Biologiques

» Start this Course
(Practice similar questions for free)
Question:

Romosozumab (Evenity)

Author: Natalia Abesada



Answer:

Inhibiteur de la sclerostine: augmente la formation osseuse et diminue la resoprtion osseuse. Ind: osteoporose post menopausique chez femmes a risque elevé de fractures.


0 / 5  (0 ratings)

1 answer(s) in total